Lithium delays progression of amyotrophic lateral sclerosis

ALS is a devastating neurodegenerative disorder with no effective treatment. In the present study, we found that daily doses of lithium, leading to plasma levels ranging from 0.4 to 0.8 mEq/liter, delay disease progression in human patients affected by ALS. None of the patients treated with lithium...

Full description

Saved in:
Bibliographic Details
Main Authors: Fornai, Francesco, Longone, Patrizia, Cafaro, Luisa, Kastsiuchenka, Olga, Ferrucci, Michela, Manca, Maria Laura, Lazzeri, Gloria, Spalloni, Alida, Bellio, Natascia, Lenzi, Paola, Modugno, Nicola, Siciliano, Gabriele, Isidoro, Ciro, Murri, Luigi, Ruggieri, Stefano, Paparelli, Antonio
Format: Artigo
Language:Inglês
Published: National Academy of Sciences 2008
Subjects:
Biological Sciences
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2538879/
https://ncbi.nlm.nih.gov/pubmed/18250315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0708022105
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items